Amy M. Richards

1.2k total citations
10 papers, 932 citations indexed

About

Amy M. Richards is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Amy M. Richards has authored 10 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Neurology. Recurrent topics in Amy M. Richards's work include Neurogenetic and Muscular Disorders Research (3 papers), RNA modifications and cancer (2 papers) and Muscle Physiology and Disorders (2 papers). Amy M. Richards is often cited by papers focused on Neurogenetic and Muscular Disorders Research (3 papers), RNA modifications and cancer (2 papers) and Muscle Physiology and Disorders (2 papers). Amy M. Richards collaborates with scholars based in United States, Cameroon and France. Amy M. Richards's co-authors include Lamya S. Shihabuddin, Seng H. Cheng, S. Pablo Sardi, Marco A. Passini, Jie Bu, Catherine R. O’Riordan, Lisa M. Stanek, Yimin Hua, Edward M. Kaye and Frank Rigo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Scientific Reports.

In The Last Decade

Amy M. Richards

10 papers receiving 912 citations

Peers

Amy M. Richards
Kathryn Koszka United States
Lucy E. Walmsley United Kingdom
Thanh T. Le United States
Christine J. DiDonato United States
Daniel D. Coovert United States
Elizabeth Kichula United States
Hannah K. Shorrock United Kingdom
Amy M. Richards
Citations per year, relative to Amy M. Richards Amy M. Richards (= 1×) peers Stéphanie Astord

Countries citing papers authored by Amy M. Richards

Since Specialization
Citations

This map shows the geographic impact of Amy M. Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy M. Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy M. Richards more than expected).

Fields of papers citing papers by Amy M. Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy M. Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy M. Richards. The network helps show where Amy M. Richards may publish in the future.

Co-authorship network of co-authors of Amy M. Richards

This figure shows the co-authorship network connecting the top 25 collaborators of Amy M. Richards. A scholar is included among the top collaborators of Amy M. Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy M. Richards. Amy M. Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rosen, Allison D., Sae Takada, Catherine Juillard, et al.. (2025). Unpacking the link between substance use disorders and 30‐day unplanned readmission. Addiction. 120(12). 2538–2546. 1 indexed citations
2.
Viel, Catherine, Jennifer Clarke, Can Kayatekin, et al.. (2021). Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model. Scientific Reports. 11(1). 20945–20945. 16 indexed citations
3.
Sardi, S. Pablo, Catherine Viel, Jennifer Clarke, et al.. (2017). Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models. Proceedings of the National Academy of Sciences. 114(10). 2699–2704. 161 indexed citations
4.
Passini, Marco A., Jie Bu, Amy M. Richards, et al.. (2014). Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9–Survival Motor Neuron 1 for Spinal Muscular Atrophy. Human Gene Therapy. 25(7). 619–630. 72 indexed citations
5.
Shiyanbola, Olayinka O., et al.. (2012). Evaluation of a student-led interprofessional innovative health promotion model for an underserved population with diabetes: A pilot project. Journal of Interprofessional Care. 26(5). 376–382. 13 indexed citations
6.
Lal, Bhavya, et al.. (2012). An Outcome Evaluation of the National Institutes of Health (NIH) Director's Pioneer Award (NDPA) Program, FY 2004-2006. 5 indexed citations
7.
Passini, Marco A., Jie Bu, Amy M. Richards, et al.. (2011). Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy. Science Translational Medicine. 3(72). 72ra18–72ra18. 415 indexed citations
8.
Passini, Marco A., Jie Bu, Eric M. Roskelley, et al.. (2010). CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy. Journal of Clinical Investigation. 120(4). 1253–1264. 235 indexed citations
9.
Richards, Amy M. & Elizabeth Krauter. (1999). Cue Competition in Prospective Memory. Psychological Reports. 85(3). 1011–1024. 1 indexed citations
10.
Richards, Amy M.. (1985). College Composition: Recognizing the Learning Disabled Writer. Journal of Basic Writing. 4(2). 68–79. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026